Preparation method of succinyl gelatin injection

By controlling the preparation process of succinyl gelatin injection, including steps such as hydrolysis, heat preservation, and filtration, the problems of weight-average molecular weight and bacterial endotoxin content have been solved, thus achieving the efficacy and safety of the drug, making it suitable for industrial production.

CN118924680APending Publication Date: 2024-11-12SICHUAN GOWELL PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310528138.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-11
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing methods for preparing succinyl gelatin injections make it difficult to effectively control weight-average molecular weight and bacterial endotoxin content, thus affecting the efficacy and safety of the drug.

Method used

The process involves steps such as sol-gelatinization, hydrolysis, quenching, acylation, heat preservation, and filtration to control the weight-average molecular weight of succinyl gelatin injection within the range of 20,000-33,000 and reduce the bacterial endotoxin content to less than 0.25 EU/ml by adjusting process parameters such as hydrolysis time, heat preservation parameters, and filtration rate.

Benefits of technology

Ensuring that the weight-average molecular weight of succinyl gelatin injection is within the limit and that the bacterial endotoxin content is low improves the efficacy and safety of the drug, making it suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004223489260000091
    Figure BDA0004223489260000091
  • Figure BDA0004223489260000151
    Figure BDA0004223489260000151
Patent Text Reader

Abstract

The embodiment of the invention discloses a preparation method of a succinyl gelatin injection, which comprises the following steps: (1) dissolving gelatin: adding water for injection into gelatin for swelling, stirring and heating until the gelatin is completely dissolved to obtain a gelatin solution; (2) hydrolysis: adding a sodium hydroxide solution into the gelatin solution for hydrolysis; (3) quenching and acylation: adding a hydrochloric acid solution into the solution obtained in the step (2) for neutralization, and then adding succinic anhydride for acylation; (4) preserving heat: adjusting the pH value of the solution obtained in the step (3) to a first range, heating to a first temperature, and preserving heat for a first time; (5) filtering: cooling and filtering the solution obtained in the step (4) to obtain a succinyl gelatin concentrated solution; and (6) diluting, filling and sterilizing the succinyl gelatin concentrated solution to obtain the succinyl gelatin injection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of medical technology, and in particular to a method for preparing succinylated gelatin injection. Background Art

[0002] Succinylated gelatin injection is a commonly used drug in the medical field. It can be used for the early treatment of hypovolemic shock caused by various reasons, such as blood loss, acute trauma or surgery, burns, sepsis, etc., or for stabilizing blood circulation and diluting extracorporeal circulation fluid before, during and after surgery, and for preventing hypotension that may occur after spinal or epidural anesthesia.

[0003] Succinylated gelatin injection is a multi-component macromolecular biochemical drug with complex ingredients. The weight average molecular weight is a key quality attribute indicator of blood volume expanders such as succinylated gelatin injection, which is related to the effectiveness and safety of the drug. Therefore, it is necessary to control the weight average molecular weight of succinylated gelatin injection within an appropriate range.

[0004] Bacterial endotoxins are unique structures on the outer layer of the cell wall of Gram-negative bacteria. Their active ingredients are mainly lipopolysaccharides (LPS), which are released after cell death or lysis. Endotoxins entering the human body may cause serious consequences such as fever, microcirculatory disorders, endotoxemia, septic shock and disseminated intravascular coagulation. Guidelines 9251 of the four parts of the 2020 edition of the Chinese Pharmacopoeia stipulates: For large infusion preparations with a volume of 100ml or more, the bacterial endotoxin limit shall generally not exceed 0.50EU / ml. The raw material for the preparation of succinylated gelatin injection is gelatin, which generally has a high level of bacterial endotoxins. If the content of bacterial endotoxins in the prepared succinylated gelatin injection is too high, it will affect the safe use of succinylated gelatin injection.

[0005] Therefore, it is necessary to provide a method for preparing succinylated gelatin injection to ensure the drug effectiveness and safety of the prepared succinylated gelatin injection. Summary of the invention

[0006] The present application provides a method for preparing a succinylated gelatin injection, which comprises: (1) sol: adding water for injection to gelatin for swelling, stirring and heating until completely dissolved to obtain a gelatin solution; (2) hydrolysis: adding sodium hydroxide solution to the gelatin solution for hydrolysis; (3) quenching and acylation: adding hydrochloric acid solution to the solution obtained in step (2) for neutralization, and then adding succinic anhydride for acylation; (4) heat preservation: adjusting the pH of the solution obtained in step (3) to a first range, then heating to a first temperature, and heat preservation for a first time; (5) filtration: cooling and filtering the solution obtained in step (4) to obtain a succinylated gelatin concentrated solution; (6) diluting, filling and sterilizing the succinylated gelatin concentrated solution to obtain a succinylated gelatin injection.

[0007] In some embodiments, the hydrolysis time comprises 80-130 s.

[0008] In some embodiments, the first range includes 7.0-8.2.

[0009] In some embodiments, the first temperature comprises 100-125°C.

[0010] In some embodiments, the first time comprises 40-100 min.

[0011] In some embodiments, the temperature after cooling comprises 50-80°C.

[0012] In some embodiments, the filtering filter element includes at least one of a polyethersulfone filter element, a polypropylene filter element, an activated carbon filter element, a polytetrafluoroethylene filter element, a glass fiber filter element, and a deep filter element.

[0013] In some embodiments, the filtration rate is ≤ 600 L / h / m 2 In some embodiments, the filtration rate of the filtration comprises 70-400 L / h / m 2 .

[0014] In some embodiments, the weight average molecular weight of succinylated gelatin injection is 20,000-33,000, and the bacterial endotoxin content is less than or equal to 0.25 EU / ml.

[0015] The present application example provides a method for preparing succinylated gelatin injection, which has the following beneficial effects:

[0016] (1) By adopting the process operations of hydrolysis, adjusting the pH of the solution before heat preservation, heat preservation, filtration and sterilization in the technical solution of the present invention, the weight average molecular weight of succinylated gelatin injection can be controlled within the weight average molecular weight limit, and the content of bacterial endotoxins can be reduced (the content of bacterial endotoxins is <0.25EU / ml) to be within the bacterial endotoxin limit, thereby ensuring the drug effectiveness and safety of succinylated gelatin injection;

[0017] (2) By adopting the process operation in the technical solution of the present invention, the hydrolysis time, the insulation parameters and the filtration speed are controlled within a suitable range (for example, the hydrolysis time is 80-130s, the pH of the solution is adjusted to 7.0-8.2 before insulation, the insulation time is 40-100min, the insulation temperature is 100-125°C, and the filtration speed is ≤600L / h / m 2 ), the weight average molecular weight of the prepared succinylated gelatin injection is within the weight average molecular weight limit, and the content of bacterial endotoxin is controlled. It has high drug effectiveness and high safety in use, and is suitable for industrial production. DETAILED DESCRIPTION

[0018] In order to more clearly illustrate the technical scheme of the present invention, the technical scheme of the present invention will be described using embodiments below. It should be understood that the description of the embodiments is only for the convenience of understanding the technical scheme, rather than limiting the present invention to the specific embodiments shown. The title in this application is provided only for the sake of convenience and should not be construed as limiting the present invention in any way. The embodiment shown under any title can be combined with the embodiment shown under any other title.

[0019] In this specification, process steps are used to illustrate the operations performed according to the technical solution of the present application. It should be understood that the previous or subsequent operations are not necessarily performed precisely in order. In some embodiments, the steps can be processed in reverse order or simultaneously. In some embodiments, other operations can also be added to these processes, or one or more operations can be removed from these processes.

[0020] Due to the consistency evaluation requirements for generic drugs and original drugs, it is necessary to conduct a consistency evaluation for generic succinylated gelatin injection. However, there is no consistency evaluation guide in the technical field to guide the consistency evaluation of the succinylated gelatin injection. Therefore, the applicant designed the consistency evaluation index parameters for succinylated gelatin injection based on the instructions of the reference preparation (BRAUN MEDICAL's succinylated gelatin injection), the public standards of similar products, the four general rules of the 2020 edition of the Chinese Pharmacopoeia, and the guiding principles, and determined that the weight-average molecular weight of succinylated gelatin injection is 20,000-33,000, and the bacterial endotoxin limit does not exceed 0.50EU / ml.

[0021] In order to ensure the drug effectiveness and safety of the prepared succinylated gelatin injection, it is necessary to control the weight average molecular weight of the succinylated gelatin injection as much as possible within the weight average molecular weight limit and reduce the content of bacterial endotoxins as much as possible.

[0022] The applicant has studied the effects of preparing succinylated gelatin injection by different process steps on controlling the weight average molecular weight of succinylated gelatin injection and reducing the bacterial endotoxin content. The applicant found that when preparing succinylated gelatin injection, succinylated gelatin injection is obtained by hydrolysis, quenching, acylation, heat preservation and filtration, and by dilution, filling and sterilization. After testing, the weight average molecular weight of the succinylated gelatin injection is within the weight average molecular weight limit, and the bacterial endotoxin content is <0.25EU / ml, which is within the bacterial endotoxin limit, ensuring the drug effectiveness and safety of the prepared succinylated gelatin injection.

[0023] The present application provides a method for preparing succinylated gelatin injection, which comprises the following steps:

[0024] Step (1), sol: adding water for injection to gelatin to swell it, stirring and heating it until it is completely dissolved to obtain a gelatin solution.

[0025] In some embodiments, the gelatin can be healthy beef bone gelatin.

[0026] In some embodiments, the heating temperature may include 80-90°C. In some embodiments, the heating temperature may include 82-88°C. In some embodiments, the heating temperature may include 85-90°C. In some embodiments, the heating temperature may include 80-85°C.

[0027] In some embodiments, the gelatin solution can be a solution free of solid gelatin particles.

[0028] Step (2), hydrolysis: adding sodium hydroxide solution to the gelatin solution for hydrolysis.

[0029] In some embodiments, by adding sodium hydroxide to the solution, the pH of the solution is controlled within a suitable range (e.g., pH=12-14) to perform a hydrolysis reaction. In some embodiments, the hydrolysis temperature may include 80-90°C. In some embodiments, the hydrolysis temperature may include 82-88°C. In some embodiments, the hydrolysis temperature may include 85-90°C. In some embodiments, the hydrolysis temperature may include 80-86°C.

[0030] In some embodiments, the time of hydrolysis may include 80-130s. In some embodiments, the time of hydrolysis may include 90-120s. In some embodiments, the time of hydrolysis may include 100-110s. In some embodiments, the time of hydrolysis may include 85-105s. In some embodiments, the time of hydrolysis may include 80-110s.

[0031] Step (3), quenching and acylation: add hydrochloric acid solution to the solution obtained in step (2) for neutralization, and then add succinic anhydride for acylation.

[0032] By adding hydrochloric acid solution to the solution, the sodium hydroxide in the solution can be neutralized, and the pH of the solution can be controlled within a suitable range (eg, pH=9-11) before the acylation reaction is carried out.

[0033] Step (4), keeping warm: adjusting the pH of the solution obtained in step (3) to a first range, heating the solution to a first temperature, and keeping the temperature warm for a first time.

[0034] In some embodiments, the temperature of the solution may be reduced to 40-70° C. before pH adjustment. In some embodiments, the temperature of the solution may be reduced to 45-65° C. before pH adjustment. In some embodiments, the temperature of the solution may be reduced to 50-60° C. before pH adjustment. In some embodiments, the temperature of the solution may be reduced to 55-68° C. before pH adjustment.

[0035] In some embodiments, sodium hydroxide solution can be added to the solution to adjust the pH of the solution. In some embodiments, hydrochloric acid solution can also be added to the solution to adjust the pH of the solution. In some embodiments, the first range can include 7.0-8.2. In some embodiments, the first range can include 7.2-8.0. In some embodiments, the first range can include 7.5-8.0. In some embodiments, the first range can include 7.2-7.8. In some embodiments, the first range can include 7.0-7.4.

[0036] In some embodiments, the first temperature may include 100-125° C. In some embodiments, the first temperature may include 105-125° C. In some embodiments, the first temperature may include 110-120° C. In some embodiments, the first temperature may include 100-115° C.

[0037] In some embodiments, the first time may include 40-100 min. In some embodiments, the first time may include 45-95 min. In some embodiments, the first time may include 50-90 min. In some embodiments, the first time may include 60-95 min. In some embodiments, the first time may include 70-80 min.

[0038] In some embodiments, the solution may be continuously stirred during the sol, hydrolysis and acylation processes.

[0039] Step (5), filtering: cooling the solution obtained in step (4) and filtering to obtain a succinylated gelatin concentrated solution.

[0040] In some embodiments, the temperature after cooling can include 50-80° C. In some embodiments, the temperature after cooling can include 55-75° C. In some embodiments, the temperature after cooling can include 60-70° C. In some embodiments, the temperature after cooling can include 65-75° C.

[0041] In some embodiments, the filtering operation can be achieved by a filter. In some embodiments, the filter element of the filter can include at least one of a polyethersulfone filter element, a polypropylene filter element, an activated carbon filter element, a polytetrafluoroethylene filter element, a glass fiber filter element, and a deep filter element.

[0042] In some embodiments, the filtration operation can be controlled by controlling the speed at which the solution flows through the filter element. In some embodiments, the filtration speed of the filtration can be ≤600 L / h / m 2 In some embodiments, the filtration rate can be ≤550 L / h / m 2 In some embodiments, the filtration rate of the filtration may be ≤500 L / h / m 2 In some embodiments, the filtration rate can be ≤450 L / h / m 2 In some embodiments, the filtration rate of the filtration may be ≤400 L / h / m 2 In some embodiments, the filtration rate can be ≤350 L / h / m 2 In some embodiments, the filtration rate can be ≤300 L / h / m 2 In some embodiments, the average filtration rate of the filtration may include 70-400 L / h / m 2 In some embodiments, the average filtration rate of the filtration may include 100-350 L / h / m 2 In some embodiments, the average filtration rate of the filtration may include 150-300 L / h / m 2 In some embodiments, the average filtration rate of the filtration may include 200-250 L / h / m 2 .

[0043] Step (6), diluting, filling and sterilizing the succinylated gelatin concentrated solution to obtain the succinylated gelatin injection.

[0044] In some embodiments, water for injection and sodium chloride can be added to the concentrated solution of succinylated gelatin, and the pH value can be adjusted (for example, pH = 7.1-7.7) and filtered again to obtain a diluted solution, which is then bagged, filled and sterilized (sterilization conditions are F0 ≥ 12) to obtain a succinylated gelatin injection solution.

[0045] In some embodiments, the weight average molecular weight of succinylated gelatin injection may include 20000-33000. In some embodiments, the weight average molecular weight of succinylated gelatin injection may include 22000-32000. In some embodiments, the weight average molecular weight of succinylated gelatin injection may include 24000-31000. In some embodiments, the weight average molecular weight of succinylated gelatin injection may include 25000-30000. In some embodiments, the weight average molecular weight of succinylated gelatin injection may include 26000-33000.

[0046] In some embodiments, the bacterial endotoxin content of succinylated gelatin injection is less than or equal to 0.5EU / ml. In some embodiments, the bacterial endotoxin content of succinylated gelatin injection is less than or equal to 0.48EU / ml. In some embodiments, the bacterial endotoxin content of succinylated gelatin injection is less than or equal to 0.42EU / ml. In some embodiments, the bacterial endotoxin content of succinylated gelatin injection is less than or equal to 0.36EU / ml. In some embodiments, the bacterial endotoxin content of succinylated gelatin injection is less than or equal to 0.3EU / ml. In some embodiments, the bacterial endotoxin content of succinylated gelatin injection is less than or equal to 0.25EU / ml. In some embodiments, the bacterial endotoxin content of succinylated gelatin injection is less than or equal to 0.24EU / ml. In some embodiments, the bacterial endotoxin content of succinylated gelatin injection is less than or equal to 0.18EU / ml. In some embodiments, the bacterial endotoxin content of succinylated gelatin injection is less than or equal to 0.12EU / ml. In some embodiments, the bacterial endotoxin content of the succinylated gelatin injection is less than or equal to 0.06 EU / ml. Example

[0047] The preparation method of succinylated gelatin injection is described in detail below through Examples 1-14. It should be noted that the reaction conditions, reaction materials and the amounts of reaction materials in Examples 1-14 are only for illustrating the preparation method of succinylated gelatin injection and do not limit the protection scope of this application.

[0048] Weight average molecular weight detection method: Determine according to molecular exclusion chromatography (Chinese Pharmacopoeia 2020 Edition Part IV General Rules 0514). Take a sample to prepare a test solution, inject the test solution into a liquid chromatograph, record the chromatogram, process it with GPC (Astra) dedicated software, and calculate the weight average molecular weight of the test sample. Limit: The weight average molecular weight (Mw) of succinylated gelatin injection should be 20,000-33,000.

[0049] Bacterial endotoxin detection method: Take samples and check according to the law (General Rules 1143 of Part IV of the 2020 Edition of the Chinese Pharmacopoeia). Limit: The amount of bacterial endotoxin contained in each 1ml of succinylated gelatin injection should be less than 0.5EU. Example 1

[0050] 1. Preparation of succinylated gelatin concentrated solution

[0051] Gelatin is swelled with water for injection, and then heated to dissolve until the solution temperature reaches 83°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 100s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the solution pH to 7.0. Seal the reactor, heat to 125°C and keep warm, and control the insulation time to 75min. After the insulation is completed, cool down to 60°C and filter using a polypropylene filter element and a polyethersulfone filter element (filtration rate 200-300L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0052] 2. Preparation of succinylated gelatin injection

[0053] Take out 40g of pure succinylated gelatin concentrated solution, add sodium chloride, and then add water for injection to a total volume of 1000L, stir to dissolve, adjust the pH to 7.1-7.7, take samples to determine the content, filter and put into an infusion bag after passing the test, and sterilize at 121°C for 15min (sterilization condition is F0≥12) to obtain succinylated gelatin injection. Example 2

[0054] 1. Preparation of succinylated gelatin concentrated solution

[0055] Gelatin is swollen with water for injection, and then heated to dissolve until the solution temperature reaches 90°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 100s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the solution pH to 7.5. After completion, the temperature is cooled to a suitable temperature and filtered using a polypropylene filter element and a polyethersulfone filter element (filtration speed 300-500L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0056] 2. Preparation of succinylated gelatin injection

[0057] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details.

[0058] The difference between Example 2 and Example 1 is that in Example 2, the solution is not kept warm. Example 3

[0059] 1. Preparation of succinylated gelatin concentrated solution

[0060] Gelatin is swollen with water for injection, and then heated to dissolve until the solution temperature reaches 80°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 92s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the solution pH to 7.0. The reactor is sealed, heated to 122°C for insulation, and the insulation time is controlled to 43min. After the insulation is completed, the temperature is lowered to a suitable temperature to obtain a succinylated gelatin concentrated solution.

[0061] 2. Preparation of succinylated gelatin injection

[0062] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details.

[0063] The difference between Example 3 and Example 1 is that in Example 3, the solution is not filtered. Example 4

[0064] 1. Preparation of succinylated gelatin concentrated solution

[0065] Gelatin is swollen with water for injection, and then heated to dissolve until the solution temperature reaches 85°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 85s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation. Seal the reactor, heat to 121°C and keep warm, and control the insulation time to 65min. After the insulation is completed, cool to a suitable temperature and filter using an activated carbon filter element or a glass fiber filter element (filtration speed 100-300L / h / m 2 ). Sodium hydroxide or hydrochloric acid is added to adjust the pH of the solution to 7.4 to obtain a concentrated succinylated gelatin solution.

[0066] 2. Preparation of succinylated gelatin injection

[0067] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details.

[0068] The difference between Example 4 and Example 1 is that in Example 4, the pH of the solution was not adjusted before incubation, but was adjusted after filtration.

[0069] The gelatin solutions and succinylated gelatin injections in Examples 1-4 were tested for weight average molecular weight and bacterial endotoxin. The results are shown in Table 1.

[0070] Table 1:

[0071] As shown in Table 1, by comparing the results of Examples 1-4, it can be seen that: the weight average molecular weight of the succinylated gelatin injection in Example 1 is within the weight average molecular weight limit (20000-33000), and the content of bacterial endotoxin is less than the bacterial endotoxin limit (less than 0.5EU / ml); while the weight average molecular weight of the succinylated gelatin injection in Example 2 is 46000, which has exceeded the weight average molecular weight limit, and the content of bacterial endotoxin is 0.36-0.6EU / ml, which is close to or exceeds the bacterial endotoxin limit; although the weight average molecular weight of the succinylated gelatin injection in Example 3 is within the weight average molecular weight limit, the content of bacterial endotoxin is 0.48-0.72EU / ml, which is close to or exceeds the bacterial endotoxin limit; the content of bacterial endotoxin of the succinylated gelatin injection in Example 4 is less than the bacterial endotoxin limit (less than 0.5EU / ml), but the weight average molecular weight is much less than the weight average molecular weight limit.

[0072] It can be seen that compared with the process operations in Example 2 in which the insulation step was omitted, Example 3 in which the filtration step was omitted, and Example 4 in which the operation of adjusting the pH of the solution after acylation was placed after filtration, Example 1 can control the weight average molecular weight of the succinylated gelatin injection within the weight average molecular weight limit and reduce the content of bacterial endotoxins to within the bacterial endotoxin limit by adjusting the pH of the solution after acylation, insulation and filtration.

[0073] Based on the above-determined process flow, the applicant further studied the effects of process parameters on the weight-average molecular weight and bacterial endotoxin of succinylated gelatin injection. Example 5

[0074] 1. Preparation of succinylated gelatin concentrated solution

[0075] Gelatin is swelled with water for injection, and then heated to dissolve until the solution temperature reaches 82°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 80s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the solution pH to 8.2. Seal the reactor, heat to 100°C and keep warm, and control the insulation time to 100min. After the insulation is completed, cool to an appropriate temperature and filter through a deep filter element and a polyethersulfone filter element (filtration rate 200-300L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0076] 2. Preparation of succinylated gelatin injection

[0077] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details. Example 6

[0078] 1. Preparation of succinylated gelatin concentrated solution

[0079] Gelatin is swelled with water for injection, and then heated to dissolve until the solution temperature reaches 90°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 130s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the solution pH to 7.5. Seal the reactor, heat to 123°C and keep warm, and control the insulation time to 40min. After the insulation is completed, cool to an appropriate temperature and filter using an activated carbon filter element and a polyethersulfone filter element (filtration rate 500-600L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0080] 2. Preparation of succinylated gelatin injection

[0081] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details. Example 7

[0082] 1. Preparation of succinylated gelatin concentrated solution

[0083] Gelatin is swelled with water for injection, and then heated to dissolve until the solution temperature reaches 83°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 140s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the solution pH to 7.3. Seal the reactor, heat to 115°C and keep warm, and control the insulation time to 50min. After the insulation is completed, cool to an appropriate temperature and filter using a glass fiber filter element and a polyethersulfone filter element (filtration rate 200-300L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0084] 2. Preparation of succinylated gelatin injection

[0085] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details. Example 8

[0086] 1. Preparation of succinylated gelatin concentrated solution

[0087] Gelatin is swelled with water for injection, and then heated to dissolve until the solution temperature reaches 83°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to be 100s. Hydrochloric acid is then added for neutralization, succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the solution pH to 7.0. Seal the reactor, heat to 113°C and keep warm, and control the insulation time to 38min. After the insulation is completed, cool to an appropriate temperature and filter using a deep filter element and a polytetrafluoroethylene filter element (filtration rate 100-300L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0088] 2. Preparation of succinylated gelatin injection

[0089] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details. Example 9

[0090] 1. Preparation of succinylated gelatin concentrated solution

[0091] Gelatin is swelled with water for injection, and then heated to dissolve until the solution temperature reaches 83°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 80s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the solution pH to 7.0. Seal the reactor, heat to 120°C and keep warm, and control the insulation time to 105min. After the insulation is completed, cool to an appropriate temperature and filter using a polypropylene filter element and a polyethersulfone filter element (filtration rate 500-600L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0092] 2. Preparation of succinylated gelatin injection

[0093] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details. Example 10

[0094] 1. Preparation of succinylated gelatin concentrated solution

[0095] Gelatin is swelled with water for injection, and then heated to dissolve until the solution temperature reaches 85°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 90s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the pH of the solution to 7.2. Seal the reactor, heat to 128°C and keep warm, and control the insulation time to 80min. After the insulation is completed, cool to an appropriate temperature and filter using a polypropylene filter element and a polyethersulfone filter element (filtration rate 200-300L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0096] 2. Preparation of succinylated gelatin injection

[0097] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details. Embodiment 11

[0098] 1. Preparation of succinylated gelatin concentrated solution

[0099] Gelatin is swelled with water for injection, and then heated to dissolve until the solution temperature reaches 88°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 98s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the pH of the solution to 7.6. Seal the reactor, heat to 98°C and keep warm, and control the insulation time to 50min. After the insulation is completed, cool to an appropriate temperature and filter using a deep filter element and a polyethersulfone filter element (filtration rate 200-300L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0100] 2. Preparation of succinylated gelatin injection

[0101] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details. Example 12

[0102] 1. Preparation of succinylated gelatin concentrated solution

[0103] Add injection water to the gelatin to swell, then heat until dissolved, until the solution temperature reaches 88°C. Add sodium hydroxide solution to the gelatin solution for hydrolysis, control the hydrolysis time to 72s, and then add hydrochloric acid for neutralization. Add succinic anhydride to the gelatin solution for acylation, and add sodium hydroxide or hydrochloric acid to adjust the solution pH to 7.3. Seal the reactor, heat to 120°C and keep warm, and control the insulation time to 75min. After the insulation is completed, cool to an appropriate temperature and filter using a polypropylene filter element and a polytetrafluoroethylene filter element (filtration rate is 700L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0104] 2. Preparation of succinylated gelatin injection

[0105] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details. Example 13

[0106] 1. Preparation of succinylated gelatin concentrated solution

[0107] Gelatin is swelled with water for injection, and then heated to dissolve until the solution temperature reaches 85°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 88s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the solution pH to 6.5. Seal the reactor, heat to 120°C and keep warm, and control the insulation time to 43min. After the insulation is completed, cool to an appropriate temperature and filter using an activated carbon filter element and glass fiber (filtration rate 200-300L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0108] 2. Preparation of succinylated gelatin injection

[0109] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details. Embodiment 14

[0110] 1. Preparation of succinylated gelatin concentrated solution

[0111] Gelatin is swelled with water for injection, and then heated to dissolve until the solution temperature reaches 85°C. Sodium hydroxide solution is added to the gelatin solution for hydrolysis, and the hydrolysis time is controlled to 75s, and then hydrochloric acid is added for neutralization. Succinic anhydride is added to the gelatin solution for acylation, and sodium hydroxide or hydrochloric acid is added to adjust the solution pH to 8.5. Seal the reactor, heat to 120°C and keep warm, and control the insulation time to 65min. After the insulation is completed, cool to an appropriate temperature and filter using a polypropylene filter element and a polytetrafluoroethylene filter element (filtration rate 100-200L / h / m 2 ) to obtain a concentrated solution of succinylated gelatin.

[0112] 2. Preparation of succinylated gelatin injection

[0113] The preparation of succinylated gelatin injection is the same as that in Example 1, and please refer to Example 1 for details.

[0114] The gelatin solutions and succinylated gelatin injections in Examples 5-14 were tested for weight average molecular weight and bacterial endotoxin. The results of Example 1 and Examples 5-14 are shown in Table 2.

[0116] As shown in Table 2, by comparing the results of Examples 1, 5-6 and 7, it can be seen that the hydrolysis time of Examples 1 and 5-6 is 100s, 80s and 130s, the weight average molecular weight of the succinylated gelatin injection is within the weight average molecular weight limit, and the bacterial endotoxin content (<0.12EU / ml or 0.12-0.24EU / ml) is less than the bacterial endotoxin limit; the hydrolysis time of Example 7 is 140s, and although the bacterial endotoxin content (<0.12EU / ml) of the succinylated gelatin injection is less than the bacterial endotoxin limit, the weight average molecular weight (19250) is less than the weight average molecular weight limit. It can be seen that when the hydrolysis time is within the range of 80-130s, the weight average molecular weight of the prepared succinylated gelatin injection is within the weight average molecular weight limit, and the bacterial endotoxin content is less than the bacterial endotoxin limit.

[0117] As shown in Table 2, by comparing the results of Examples 1, 5-6 and 8-9, it can be seen that: the insulation time of Examples 1 and 5-6 is 75 min, 100 min and 40 min, the weight average molecular weight of succinylated gelatin injection is within the weight average molecular weight limit, and the bacterial endotoxin content (<0.12EU / ml or 0.12-0.24EU / ml) is less than the bacterial endotoxin limit; the insulation time of Example 8 is 38 min, and the weight average molecular weight (32460) of succinylated gelatin injection is within the weight average molecular weight limit, but close to the upper limit of the weight average molecular weight, and the bacterial endotoxin content (0.72-0.9EU / ml) is greater than the bacterial endotoxin limit; the insulation time of Example 9 is 105 min, and the bacterial endotoxin content (<0.12EU / ml) of succinylated gelatin injection is less than the bacterial endotoxin limit, but the weight average molecular weight (20160) is close to the lower limit of the weight average molecular weight. It can be seen that in order to ensure that the weight average molecular weight of the prepared succinylated gelatin injection is within the weight average molecular weight limit and the bacterial endotoxin content is less than the bacterial endotoxin limit, the insulation time can be controlled within the range of 40-100 min.

[0118] As shown in Table 2, by comparing the results of Examples 1, 5-6 and 10-11, it can be seen that: the insulation temperatures of Examples 1 and 5-6 are 125°C, 100°C and 123°C, the weight average molecular weight of the succinylated gelatin injection is within the weight average molecular weight limit, and the bacterial endotoxin content (<0.12EU / ml or 0.12-0.24EU / ml) is less than the bacterial endotoxin limit; the insulation temperature of Example 10 is 128°C, the bacterial endotoxin content of the succinylated gelatin injection (<0.12EU / ml) is less than the bacterial endotoxin limit, and the weight average molecular weight (21620) is close to the lower limit of the weight average molecular weight; the insulation temperature of Example 11 is 98°C, and the weight average molecular weight (32600) of the succinylated gelatin injection is within the weight average molecular weight limit, but close to the upper limit of the weight average molecular weight, and the bacterial endotoxin content (0.6-0.72EU / ml) is greater than the bacterial endotoxin limit. It can be seen that in order to ensure that the weight average molecular weight of the prepared succinylated gelatin injection is within the weight average molecular weight limit and the bacterial endotoxin content is less than the bacterial endotoxin limit, the insulation temperature can be controlled within the range of 100-125°C.

[0119] As shown in Table 2, by comparing the results of Examples 1, 5-6 and 13-14, it can be seen that: the pH of the solution before heating in the insulation step of Examples 1 and 5-6 is 7.0, 8.2 and 7.5, the weight average molecular weight of the succinylated gelatin injection is within the weight average molecular weight limit, and the bacterial endotoxin content (<0.12EU / ml or 0.12-0.24EU / ml) is less than the bacterial endotoxin limit; the pH of the solution before heating in the insulation step in Example 13 is 6.5, the bacterial endotoxin content of the succinylated gelatin injection (<0.12EU / ml) is less than the bacterial endotoxin limit, and the weight average molecular weight (20180) is close to the lower limit of the weight average molecular weight; the pH of the solution before heating in the insulation step in Example 14 is 8.5, the bacterial endotoxin content of the succinylated gelatin injection (<0.12EU / ml) is less than the bacterial endotoxin limit, and the weight average molecular weight (21200) is close to the lower limit of the weight average molecular weight. It can be seen that in order to ensure that the weight average molecular weight of the prepared succinylated gelatin injection is within the weight average molecular weight limit and the bacterial endotoxin content is less than the bacterial endotoxin limit, the pH of the solution before heating in the insulation step can be controlled within the range of 7.0-8.2.

[0120] As shown in Table 2, by comparing the results of Examples 1, 5-6 and Example 12, it can be seen that the filtration speed of Examples 1 and 5-6 is 200-300 L / h / m 2 、200-300L / h / m 2 and 500-600L / h / m 2 The weight average molecular weight of succinylated gelatin injection is within the weight average molecular weight limit, and the bacterial endotoxin content (<0.12EU / ml or 0.12-0.24EU / ml) is less than the bacterial endotoxin limit; the filtration speed of Example 12 is too fast (the filtration speed is 700L / h / m 2 ), the weight average molecular weight of succinylated gelatin injection (28120) is within the weight average molecular weight limit, but the bacterial endotoxin content (0.48-0.6EU / ml) is close to or exceeds the bacterial endotoxin limit. It can be seen that in order to ensure that the weight average molecular weight of the prepared succinylated gelatin injection is within the weight average molecular weight limit and the bacterial endotoxin content is less than the bacterial endotoxin limit, the filtration speed can be controlled to ≤600L / h / m 2 .

[0121] In summary, by adopting the process operation in the technical solution of the present invention, and the hydrolysis time, insulation parameters and filtration speed are within a suitable range (for example, the hydrolysis time is 80-130s, the pH of the solution is adjusted to 7.0-8.2 before heating, the insulation time is 40-100min, the insulation temperature is 100-125°C, and the filtration speed is ≤600L / h / m 2), the weight average molecular weight of the prepared succinylated gelatin injection is within the weight average molecular weight limit, and the content of bacterial endotoxin is controlled. It has high drug effectiveness and high safety in use, and is suitable for industrial production.

[0122] The basic concepts have been described above. Obviously, for those skilled in the art, the above detailed disclosure is only an example and does not constitute a limitation of the present application. Without paying creative work, those skilled in the art may make various modifications, improvements and amendments to the present application. Such modifications, improvements and amendments still belong to the spirit and scope of the exemplary embodiments of this specification. All methods described herein can be performed in any suitable order, unless otherwise specified herein or clearly contradicted by the context.

[0123] In some embodiments, numbers describing the number of components and attributes are used. It should be understood that such numbers used in the description of the embodiments are modified by the modifiers "about", "approximately", "approximately" or "substantially" in some examples. Unless otherwise specified, "about", "approximately", "approximately" or "substantially" indicate that the number allows a change of ±20%. Accordingly, in some embodiments, the numerical parameters used in the specification and claims may be approximate values, which may change according to the characteristics required by the individual embodiments. In some embodiments, the numerical parameters should consider the specified significant digits and adopt the method of general digit retention. Although the numerical domains and parameters used to confirm the breadth of their range in some embodiments of this specification are approximate values, in specific embodiments, such numerical values ​​are set as accurately as possible within the feasible range. Unless otherwise specified herein, the enumeration of the range of values ​​herein is intended only to be used as a shorthand method for individually referring to each individual value falling within the range, and each individual value is incorporated into the specification, which is equivalent to being individually enumerated herein.

[0124] The use of any and all examples or exemplary language provided herein is intended merely to illustrate certain materials, products and methods and is not intended to limit the scope. No language in the specification should be construed as indicating any non-claimed element is essential to practice the disclosed materials, products and methods.

[0125] As shown in this application and claims, unless the context clearly indicates an exception, the words "a", "an", "an" and / or "the" do not refer to the singular and may also include the plural. Generally speaking, the terms "include" and "comprise" only indicate the inclusion of the steps and elements that have been clearly identified, and these steps and elements do not constitute an exclusive list. The method or composition may also include other steps or elements.

[0126] At the same time, this specification uses specific words to describe the embodiments of this specification. For example, "in some embodiments", "in various embodiments", "one embodiment", "an embodiment", and / or "some embodiments" refer to a certain feature, structure or characteristic related to at least one embodiment of this specification. Therefore, it should be emphasized and noted that "in some embodiments", "in various embodiments", "one embodiment", "an embodiment", and / or "some embodiments" mentioned twice or more in different positions in this specification do not necessarily refer to the same embodiment. In addition, some features, structures or characteristics in one or more embodiments of this specification can be appropriately combined.

[0127] Although the above disclosure discusses some of the invention embodiments currently considered useful through various examples, it should be understood that such details are only for illustrative purposes and the claims are not limited to the disclosed embodiments. On the contrary, the claims are intended to cover all modifications and equivalent combinations that are consistent with the essence and scope of the embodiments of this specification.

[0128] Similarly, it should be noted that in order to simplify the description disclosed in this specification and thus help understand one or more embodiments of the invention, in the description of the embodiments of this specification, multiple features are sometimes combined into one embodiment. However, this disclosure method does not mean that the features required by the subject matter of this specification are more than the features mentioned in the claims.

[0129] Each patent, patent application, patent application publication, and other materials, such as articles, books, specifications, publications, documents, etc., cited in this specification are hereby incorporated by reference in their entirety. Except for application history documents that are inconsistent with or conflicting with the contents of this specification, documents that limit the broadest scope of the claims of this specification (currently or later attached to this specification) are also excluded. It should be noted that if the descriptions, definitions, and / or use of terms in the materials attached to this specification are inconsistent or conflicting with the contents described in this specification, the descriptions, definitions, and / or use of terms in this specification shall prevail.

[0130] Finally, it should be understood that the embodiments described in this specification are only used to illustrate the principles of the embodiments of this specification. Other variations may also fall within the scope of this specification. Therefore, as an example and not a limitation, alternative compositions of the embodiments of this specification may be considered consistent with the teachings of this specification. Accordingly, the embodiments of this specification are not limited to the embodiments explicitly introduced and described in this specification.

Claims

1. A method for preparing succinylated gelatin injection, characterized in that: The preparation method comprises: (1) Sol: Add water for injection to gelatin to swell it, stir and heat until it is completely dissolved to obtain a gelatin solution; (2) hydrolysis: adding sodium hydroxide solution to the gelatin solution for hydrolysis; (3) Quenching and acylation: adding hydrochloric acid solution to the solution obtained in step (2) for neutralization, and then adding succinic anhydride for acylation; (4) keeping warm: adjusting the pH of the solution obtained in step (3) to a first range, heating the solution to a first temperature, and keeping the temperature warm for a first time; (5) Filtration: Cooling and filtering the solution obtained in step (4) to obtain a succinylated gelatin concentrated solution; (6) diluting, filling and sterilizing the succinylated gelatin concentrated solution to obtain a succinylated gelatin injection.

2. The preparation method according to claim 1, characterized in that: The hydrolysis time is comprised between 80 and 130 seconds.

3. The preparation method according to claim 1, characterized in that: The first range includes 7.0-8.

2.

4. The preparation method according to claim 1, characterized in that: The first temperature comprises 100-125°C.

5. The preparation method according to claim 1, characterized in that: The first time comprises 40-100 min.

6. The preparation method according to claim 1, characterized in that: The temperature after cooling includes 50-80°C.

7. The preparation method according to claim 1, characterized in that: The filtering element includes at least one of a polyethersulfone filter element, a polypropylene filter element, an activated carbon filter element, a polytetrafluoroethylene filter element, a glass fiber filter element, and a deep filter element.

8. The preparation method according to claim 1, characterized in that: The filtration speed of the filtration is ≤600L / h / m 2 .

9. The preparation method according to claim 8, characterized in that: The average filtration rate of the filtration includes 70-400L / h / m 2 .

10. The preparation method according to claim 1, characterized in that: The weight average molecular weight of the succinylated gelatin injection is 20,000-33,000, and the bacterial endotoxin content is less than or equal to 0.25 EU / ml.